Kazunori Fujitaka Selected Research

Kazunori Fujitaka Research Topics

Disease

33	Neoplasms (Cancer) 01/2024 - 03/2011
32	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2024 - 06/2004
26	Lung Neoplasms (Lung Cancer) 01/2024 - 03/2011
19	Interstitial Lung Diseases (Interstitial Lung Disease) 11/2023 - 12/2005
12	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2024 - 01/2009
10	Fibrosis (Cirrhosis) 01/2024 - 01/2017
9	Idiopathic Pulmonary Fibrosis 05/2024 - 04/2010
9	Lung Injury 05/2024 - 04/2009
8	Asthma (Bronchial Asthma) 10/2023 - 01/2009
8	Adenocarcinoma of Lung 01/2022 - 06/2011
6	Neoplasm Metastasis (Metastasis) 09/2020 - 03/2011
5	Adenocarcinoma 01/2023 - 03/2011
5	Disease Progression 07/2022 - 12/2018
5	Bronchiectasis 02/2021 - 01/2018
4	Pneumonia (Pneumonitis) 10/2022 - 07/2011
4	Venous Thromboembolism 01/2022 - 03/2019
3	Acute Lung Injury 05/2024 - 01/2020
3	Radiation Pneumonitis 11/2022 - 10/2021
3	Hemorrhage 01/2022 - 08/2018
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 11/2021 - 10/2017
3	Emphysema 04/2021 - 01/2016
3	Inflammation (Inflammations) 01/2021 - 11/2017
3	Lewis Lung Carcinoma 09/2018 - 11/2013
2	Carcinogenesis 11/2022 - 10/2020
2	Respiratory Insufficiency (Respiratory Failure) 02/2022 - 01/2017
2	Dyspnea (Shortness of Breath) 02/2021 - 12/2005
2	Sarcoidosis (Schaumann Disease) 01/2021 - 05/2012
2	Carcinoma (Carcinomatosis) 01/2021 - 06/2011
2	Intracranial Embolism 01/2020 - 03/2019
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2020 - 01/2015
2	Malignant Mesothelioma 01/2018 - 01/2016
2	Lymphangioleiomyomatosis (Lymphangiomyomatosis) 12/2017 - 01/2002
2	Fever (Fevers) 12/2005 - 05/2005
2	Neutropenia 05/2005 - 06/2004
1	Thromboembolism 01/2024
1	Rhinosinusitis 10/2023

Drug/Important Bio-Agent (IBA)

12	ErbB Receptors (EGF Receptor)IBA 02/2024 - 06/2008
11	Bleomycin (Blenoxane)FDA LinkGeneric 05/2024 - 01/2009
10	Biomarkers (Surrogate Marker)IBA 05/2024 - 07/2011
8	Plasminogen Activators (Plasminogen Activator)IBA 02/2023 - 04/2010
8	Plasminogen Activator Inhibitor 1IBA 02/2023 - 04/2010
8	LigandsIBA 07/2022 - 01/2016
6	Immune Checkpoint InhibitorsIBA 02/2024 - 09/2019
6	CytokinesIBA 11/2023 - 01/2009
6	Proteins (Proteins, Gene)FDA Link 01/2023 - 12/2015
6	Tyrosine Kinase InhibitorsIBA 08/2022 - 06/2008
5	HMGB1 Protein (HMG1)IBA 01/2023 - 01/2020
5	Cisplatin (Platino)FDA LinkGeneric 02/2021 - 05/2005
5	Small Interfering RNA (siRNA)IBA 01/2021 - 04/2010
4	AnticoagulantsIBA 01/2024 - 03/2019
4	Bevacizumab (Avastin)FDA Link 10/2023 - 09/2018
4	pembrolizumabIBA 01/2022 - 03/2019
4	Carboplatin (JM8)FDA LinkGeneric 11/2021 - 06/2004
4	AntibodiesIBA 11/2019 - 12/2005
3	osimertinibIBA 02/2023 - 01/2022
3	Messenger RNA (mRNA)IBA 01/2023 - 01/2021
3	Prednisolone (Predate)FDA LinkGeneric 12/2022 - 01/2018
3	SteroidsIBA 12/2022 - 12/2005
3	edoxabanIBA 01/2022 - 03/2019
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 10/2021 - 06/2011
3	Gefitinib (Iressa)FDA Link 10/2021 - 06/2011
3	AntigensIBA 04/2021 - 12/2005
3	Interleukin-6 (Interleukin 6)IBA 01/2021 - 04/2009
3	suplatast tosilateIBA 01/2019 - 01/2009
3	SK-216IBA 01/2016 - 11/2013
3	Paclitaxel (Taxol)FDA LinkGeneric 10/2011 - 06/2004
2	Hydroxyproline (4 Hydroxyproline)IBA 01/2024 - 10/2018
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2023 - 01/2021
2	AfatinibIBA 10/2023 - 01/2019
2	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2023 - 01/2022
2	Prothrombin (Factor II)IBA 01/2023 - 01/2022
2	Immunoglobulin G (IgG)IBA 12/2022 - 04/2022
2	EnzymesIBA 02/2021 - 01/2012
2	NivolumabIBA 02/2021 - 01/2018
2	PlatinumIBA 01/2021 - 01/2019
2	Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA 01/2019 - 12/2018
2	Mucin-1 (CA 15-3 Antigen)IBA 01/2019 - 12/2017
2	ChemokinesIBA 01/2019 - 01/2017
2	Pemetrexed (MTA)FDA Link 12/2018 - 09/2018
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2018 - 11/2013
2	PowdersIBA 09/2018 - 12/2015
2	Docetaxel (Taxotere)FDA Link 09/2018 - 01/2011
2	CD13 Antigens (Alanine Aminopeptidase)IBA 01/2018 - 07/2015
2	Receptor for Advanced Glycation End ProductsIBA 11/2017 - 01/2017
1	Lipocalin-2IBA 05/2024
1	Glycoproteins (Glycoprotein)IBA 05/2024
1	paquinimodIBA 01/2024
1	Hypoxia-Inducible Factor 1IBA 11/2023
1	RNA (Ribonucleic Acid)IBA 11/2023
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 11/2023

Therapy/Procedure

19	Drug Therapy (Chemotherapy) 07/2022 - 01/2011
11	Therapeutics 01/2024 - 06/2011
7	Radiotherapy 11/2022 - 06/2017
5	Chemoradiotherapy 12/2022 - 10/2017
5	Traction 02/2021 - 01/2018
2	Oral Administration 10/2022 - 06/2017
2	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 06/2022 - 12/2021
2	Nebulizers and Vaporizers (Inhaler) 01/2022 - 09/2018
2	Catheters 01/2020 - 01/2018
1	Cell Transplantation 11/2023